Presence of Soil-Dwelling Clostridia in Commercial Powdered Infant Formulas

被引:34
作者
Barash, Jason R. [1 ]
Hsia, Jennifer K. [1 ]
Arnon, Stephen S. [1 ]
机构
[1] Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Div Communicable Dis Control, Ctr Infect Dis, Richmond, CA 94804 USA
关键词
BOTULINUM; HONEY; TYROBUTYRICUM; SPOROGENES; SPECIMENS; BUTYRICUM; DIVERSITY; BARATII; STRAINS; SPORES;
D O I
10.1016/j.jpeds.2009.09.072
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Because Clostridium botulinum was isolated from powdered infant formula (PIF) fed to an infant in the United Kingdom who subsequently developed infant botulism and from unopened PIF from the same manufacturer, we tested PIF manufactured in the United States for the presence of clostridial spores. Study design Thirty PIF ingested by 19 California infants with botulism within 4 weeks of onset of illness (48% of all patients fed PIF during study) in 2006-2007 were cultured anaerobically to isolate clostridia. All isolated clostridia were identified to the species level and enumerated with standard microbiologic and molecular methods. Results Five of 30 (17%) PIF samples ingested by patients contained clostridial spores. Spores were also found in 7 of 9 (78%) market-purchased PIF samples. Clostridium sporogenes was isolated most frequently, followed by Clostridium butyricum and at least 10 other soil-dwelling clostridial species. No neurotoxigenic clostridia were isolated. The most probable number of clostridial spores in PIF ranged between 1.1 to >23 per 100 g. Conclusions With the notable exception of production of botulinum neurotoxin, C sporogenes is physiologically comparable with proteolytic strains of C botulinum, and both share the same natural reservoir (soils and dust worldwide). The isolation of C sporogenes and potentially pathogenic clostridia from U.S.-manufactured PIF suggests that neurotoxigenic clostridial spores have the potential to be present in these products. (J Pediatr 2010;156:402-8).
引用
收藏
页码:402 / 408
页数:7
相关论文
共 43 条
[1]  
[Anonymous], PED NUTR HDB
[2]  
Arnon S. S., 2004, TXB PEDIAT INFECT DI, P1758
[3]   HONEY AND OTHER ENVIRONMENTAL RISK-FACTORS FOR INFANT BOTULISM [J].
ARNON, SS ;
MIDURA, TF ;
DAMUS, K ;
THOMPSON, B ;
WOOD, RM ;
CHIN, J .
JOURNAL OF PEDIATRICS, 1979, 94 (02) :331-336
[4]   Infant botulism and honey in Europe: a commentary [J].
Aureli, P ;
Franciosa, G ;
Fenicia, L .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) :866-868
[5]   2 CASES OF TYPE-E INFANT BOTULISM CAUSED BY NEUROTOXIGENIC CLOSTRIDIUM-BUTYRICUM IN ITALY [J].
AURELI, P ;
FENICIA, L ;
PASOLINI, B ;
GIANFRANCESCHI, M ;
MCCROSKEY, LM ;
HATHEWAY, CL .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (02) :207-211
[6]   First case of infant botulism caused by Clostridium baratii type F in California [J].
Barash, JR ;
Tang, TWH ;
Arnon, SS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :4280-4282
[7]  
Borrilello S.P. e., 2005, Topley and Wilson's Microbiology and Microbial Infections, V8A edicao, P1089
[8]   A case of infant botulism with a possible link to infant formula milk powder:: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food [J].
Brett, MM ;
McLauchlin, J ;
Harris, A ;
O'Brien, S ;
Black, N ;
Forsyth, RJ ;
Roberts, D ;
Bolton, FJ .
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (08) :769-776
[9]  
*CDCP, 2006, CSTE BOT SURV SUMM A
[10]  
Center for Disease Control and Prevention, 2001, ENT SAK INF ASS US P